MARKET

XNCR

XNCR

Xencor
NASDAQ
27.14
+0.04
+0.15%
After Hours: 27.10 -0.04 -0.15% 17:00 06/01 EDT
OPEN
27.09
PREV CLOSE
27.10
HIGH
27.25
LOW
26.22
VOLUME
203.76K
TURNOVER
0
52 WEEK HIGH
38.20
52 WEEK LOW
19.36
MARKET CAP
1.64B
P/E (TTM)
-11.6152
1D
5D
1M
3M
1Y
5Y
Analysts Offer Insights on Healthcare Companies: Xencor (XNCR) and Poseida Therapeutics (PSTX)
TipRanks · 1d ago
BRIEF-Xencor Presents Clinical Results from Phase 1a Study of XmAb564 at EULAR 2023 Congress
Reuters · 3d ago
Xencor Reports Presentation Of Results From Its Phase 1a Single-Ascending Dose Study Of XmAb 564 In Healthy Volunteers; Engineered IL2-Fc Cytokine Is Well-tolerated
Benzinga · 3d ago
Viridian Therapeutics Has Promise
Seeking Alpha · 05/21 11:32
B of A Securities Initiates Coverage of Xencor (XNCR) with Buy Recommendation
NASDAQ · 05/19 23:01
Bank of America Initiates Xencor Coverage with Buy Rating
TipRanks · 05/19 19:56
Xencor a buy at BofA on protein therapeutics
Seeking Alpha · 05/19 15:27
Benzinga's Top Ratings Upgrades, Downgrades For May 19, 2023
Benzinga · 05/19 15:00
More
About XNCR
Xencor, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing engineered monoclonal antibodies and cytokine therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs. It uses protein engineering capabilities to enable its understanding of protein structures and interactions and to design technologies and XmAb drug candidates with improved properties. It is advancing its XmAb drug candidates into clinical-stage development. It is focused on the Fc domain, which is part of an antibody that interacts with various segments of the immune system and controls antibody structural architecture. The Fc domain is constant and interchangeable among antibodies, and its engineered Fc domains are the XmAb technology, which can be readily substituted for natural Fc domains. Its drug candidates include Vudalimab, XmAb104, XmAb564, XmAb819, XmAb808, Plamotamab, Obexelimab, Sotrovimab, XmAb306/RG6323, and others.

Webull offers kinds of Xencor Inc stock information, including NASDAQ:XNCR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XNCR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading XNCR stock methods without spending real money on the virtual paper trading platform.